Certified by Founder Lodge
Kurma Partners
France - Paris, Paris
INVESTOR
1 Disclosed Funding Rounds $14,955,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (cu
| Company | Date | Round | Raised |
|---|---|---|---|
Poppins |
April, 29 ,2025 | Unknown | $5,697,525 |
Kiro |
April, 03 ,2023 | Series A | $14,955,000 |
Elkedonia |
June, 11 ,2025 | Seed | $12,580,054 |
Corteria Pharmaceuticals |
September, 07 ,2023 | Series A | $69,471,000 |
Spotlight Medical |
July, 12 ,2024 | Seed | $6,760,573 |
Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
Poppins |
April, 29 ,2025 | Unknown | $5,697,525 |
Elkedonia |
June, 11 ,2025 | Seed | $12,580,054 |
Poppins
Kiro
Elkedonia
Corteria Pharmaceuticals
Spotlight Medical
Coave Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)